GGrantIndex
← Leaderboards

Laura F Gibson

West Virginia University

$10,658,122
Attributed
$10,658,122
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.1M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$23,810,264 · 11

By mechanism

P20$8,002,256 · 3
P30$7,007,838 · 3
R01$5,483,067 · 2
U54$3,112,703 · 2
R29$204,400 · 1

Top collaborators

No co-investigators on record.

Most similar at West Virginia University

Same institution · by research overlap

Others in their field

Top investigators on “Proteins

Research focus

ProteinsSignal TransductionDesignResearch PersonnelFundingIn VivoInvestigationWest VirginiaProgramsMalignant NeoplasmsResearch InfrastructureUniversitiesAppalachian RegionBaseResourcesBasic ScienceTechnologyTrainingInvestmentsMolecularAreaResearch StudySourceStem Cells

Grant awards (44)

Technologies and Resources for Core Laboratories$179,050
U54 · FY2025 · GM · contact PI
Technologies and Resources for Core Laboratories$179,050
U54 · FY2024 · GM · contact PI
Technologies and Resources for Core Laboratories$179,050
U54 · FY2023 · GM · contact PI
Technologies and Resources for Core Laboratories$387,703
U54 · FY2022 · GM · contact PI
Technologies and Resources for Core Laboratories$433,182
U54 · FY2021 · GM · contact PI
Technologies and Resources for Core Laboratories$452,118
U54 · FY2020 · GM · contact PI
Technologies and Resources for Core Laboratories$436,413
U54 · FY2019 · GM · contact PI
Technologies and Resources for Core Laboratories$433,529
U54 · FY2018 · GM · contact PI
Technologies and Resources for Core Laboratories$432,608
U54 · FY2017 · GM · contact PI
CoBRE for Signal Transduction and Cancer Phase III$386,688
P30 · FY2016 · GM · contact PI
CoBRE for Signal Transduction and Cancer Phase III$1,110,000
P30 · FY2015 · GM · contact PI
CoBRE for Signal Transduction and Cancer Phase III$1,110,000
P30 · FY2014 · GM · contact PI
Microenvironment Function Following Chemotherapy$362,600
R01 · FY2014 · HL · contact PI
CoBRE for Signal Transduction and Cancer Phase III$1,071,150
P30 · FY2013 · GM · contact PI
Microenvironment Function Following Chemotherapy$352,240
R01 · FY2013 · HL · contact PI
The Role of the Stem Cell Niche in ALL$277,176
R01 · FY2013 · CA · contact PI
CoBRE for Signal Transduction and Cancer Phase III$1,110,000
P30 · FY2012 · GM · contact PI
Microenvironment Function Following Chemotherapy$370,000
R01 · FY2012 · HL · contact PI
The Role of the Stem Cell Niche in ALL$263,553
R01 · FY2012 · CA · contact PI
COBRE FOR SIGNAL TRANSDUCTION AND CANCER PHASE III$1,110,000
P30 · FY2011 · RR · contact PI
CoBRE for Signal Transduction and Cancer Phase III$1,110,000
P30 · FY2011 · RR · contact PI
Microenvironment Function Following Chemotherapy$370,000
R01 · FY2011 · HL · contact PI
The Role of the Stem Cell Niche in ALL$294,868
R01 · FY2011 · CA · contact PI
The Role of the Stem Cell Niche in ALL$18,865
R01 · FY2011 · CA · contact PI
Cobre for Signal Transduction and Cancer$2,084,768
P20 · FY2010 · RR · contact PI
COBRE: WVU: SIGNAL TRANSDUCTION & CANCER: ADMINISTRATIVE CORE$330,644
P20 · FY2010 · RR · contact PI
The Role of the Stem Cell Niche in ALL$303,988
R01 · FY2010 · CA · contact PI
The Role of the Stem Cell Niche in ALL$25,308
R01 · FY2010 · CA · contact PI
Cobre for Signal Transduction and Cancer$2,084,768
P20 · FY2009 · RR · contact PI
Cobre for Signal Transduction and Cancer$1,000,000
P20 · FY2009 · RR · contact PI
COBRE: WVU: SIGNAL TRANSDUCTION & CANCER: ADMINISTRATIVE CORE$417,308
P20 · FY2009 · RR · contact PI
Stromal Cell Function Following Chemotherapy$329,840
R01 · FY2009 · HL · contact PI
The Role of the Stem Cell Niche in ALL$303,988
R01 · FY2009 · CA · contact PI
Cobre for Signal Transduction and Cancer$2,084,768
P20 · FY2008 · RR · contact PI
Stromal Cell Function Following Chemotherapy$330,551
R01 · FY2008 · HL · contact PI
Stromal Cell Function Following Chemotherapy$331,320
R01 · FY2007 · HL · contact PI
Stromal Cell Function Following Chemotherapy$344,270
R01 · FY2006 · HL · contact PI
Stromal Cell Function Following Chemotherapy$328,500
R01 · FY2005 · HL
Stromal Cell Function Following Chemotherapy$255,500
R01 · FY2004 · HL
VCAM-1 Mediated Regulation of ES Cell Development$73,000
R01 · FY2004 · HL
Stromal Cell Function Following Chemotherapy$255,500
R01 · FY2003 · HL
Stromal Cell Function Following Chemotherapy$292,000
R01 · FY2002 · HL
STROMAL CELL FUNCTION FOLLOWING CHEMOTHERAPY$102,200
R29 · FY2001 · HL
STROMAL CELL FUNCTION FOLLOWING CHEMOTHERAPY$102,200
R29 · FY2000 · HL